4//SEC Filing
HEGGIE THERESA 4
Accession 0001127602-24-018715
CIK 0000882796other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:25 PM ET
Size
9.1 KB
Accession
0001127602-24-018715
Insider Transaction Report
Form 4
HEGGIE THERESA
Director
Transactions
- Award
Common Stock
2024-06-12+6,820→ 59,550 total - Award
Automatic Stock Option Grant
2024-06-12+49,933→ 49,933 totalExercise: $6.30From: 2025-06-12Exp: 2034-06-12→ Common Stock (49,933 underlying) - Sale
Common Stock
2024-06-14$6.11/sh−6,698$40,925→ 52,852 total
Footnotes (4)
- [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
- [F2]These shares were sold with the sole purpose of generating sufficient proceeds to cover the tax liability incurred in connection with the vesting of 16,745 Restricted Stock Units on June 13, 2024.
- [F3]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.08 to $6.15. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- [F4]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001760020
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:25 PM ET
- Size
- 9.1 KB